Overview and Scope
Electronic drug delivery systems refer to a type of device or formulation that can enable a medical substance to reach a selective region without reaching non-target cells and tissues. Electronic drug delivery systems are used to deliver a constant and regulated dose of drugs through easy monitoring of doses.
Sizing and Forecast
The electronic drug delivery systems market size has grown strongly in recent years. It will grow from $10.54 billion in 2023 to $11.45 billion in 2024 at a compound annual growth rate (CAGR) of 8.6%. The growth in the historic period can be attributed to risen chronic diseases incidence, aging population, patient preference for non-invasive delivery, healthcare cost containment, clinical advancements and validation.
The electronic drug delivery systems market size is expected to see strong growth in the next few years. It will grow to $16.12 billion in 2028 at a compound annual growth rate (CAGR) of 8.9%. The growth in the forecast period can be attributed to increasing drug personalization, rising global healthcare expenditure, patient-centric healthcare approach, emergence of targeted therapies, supportive regulatory environment, advancements in remote patient monitoring. Major trends in the forecast period include incorporation of artificial intelligence (ai), biocompatible materials and implantable devices, customization for specific therapeutic areas, regulatory advancements and standardization, collaborations between pharma and tech companies.
To access more details regarding this report, visit the link:
https://www.thebusinessresearchcompany.com/report/electronic-drug-delivery-systems-global-market-report
Segmentation & Regional Insights
The electronic drug delivery systems market covered in this report is segmented –
1) By Type: Electronic Infusion Pumps, Electronic Injection Pens, Electronic Auto-Injectors, Electronic Inhalers, Electronic Capsules, Other Types
2) By Component: Sensors, Wireless Communicator And Antennas, Micro Pumps And Flow Regulators, Drug Reservoir, Microcontroller, Other Components
3) By System Type: Battery-Powered Systems, Rechargeable Systems
4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
5) By Application: Diabetes, Cardiovascular Disease, Respiratory Disorders, Multiple Sclerosis, Other Applications
North America was the largest region in the electronic drug delivery systems market in 2023. Asia-pacific is expected to be the fastest-growing region in the global electronic drug delivery systems market report during the forecast period. The regions covered in the electronic drug delivery systems market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Intrigued to explore the contents? Secure your hands-on sample copy of the report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10734&type=smp
Major Driver Impacting Market Growth
The rising prevalence of chronic disease is expected to propel the growth of the electronic drug delivery systems market going forward. Chronic disease refers to a condition or disease that lasts for more than a year and requires ongoing medical treatment. Electronic drug delivery systems are used for regulating drug doses and make monitoring drug doses easy for people who suffer from chronic diseases. For instance, in January 2023, according to the National Library of Medicine, a US-based agency, the number of people in the US aged 50 and older who have at least 1 chronic condition would increase to 142.66 million by 2050. Therefore, the rising prevalence of chronic diseases will drive the electronic delivery system market.
Key Industry Players
Major companies operating in the electronic drug delivery systems market report are Gerresheimer AG, Amgen Inc., Medtronic plc, Novo Nordisk A/S, Insulet Corporation, Bayer AG, AstraZeneca plc, Tandem Diabetes Care, Merck KGaA, United Therapeutics Corporation, F. Hoffmann-La Roche AG, Elcam Medical, Sanofi S.A., Canè SpA, FindAir, Johnson & Johnson Services Inc., Antares Pharma Inc, Abbott Laboratories, Adherium Ltd., H&T Presspart Manufacturing Ltd., HCmed Innovations Co. Ltd., Amiko Digital Health Limited, CeQur Corporation, Teva Pharmaceutical Industries Ltd., GlaxoSmithKline PLC, Holozymes Inc., West Pharmaceutical Services Inc., Pfizer Inc., Novartis AG, BIOCORP
The electronic drug delivery systems market report table of contents includes:
1. Executive Summary
2. Electronic Drug Delivery Systems Market Characteristics
3. Electronic Drug Delivery Systems Market Trends And Strategies
4. Electronic Drug Delivery Systems Market – Macro Economic Scenario
5. Global Electronic Drug Delivery Systems Market Size and Growth
.
.
.
31. Global Electronic Drug Delivery Systems Market Competitive Benchmarking
32. Global Electronic Drug Delivery Systems Market Competitive Dashboard
33. Key Mergers And Acquisitions In The Electronic Drug Delivery Systems Market
34. Electronic Drug Delivery Systems Market Future Outlook and Potential Analysis
35. Appendix
Explore the trending research reports from TBRC:
https://www.thebusinessresearchcompany.com/report/drug-delivery-devices-global-market-report
https://www.thebusinessresearchcompany.com/report/drugs-for-immunotherapy-global-market-report
https://www.thebusinessresearchcompany.com/report/monoclonal-antibodies-global-market-report
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
